The Safety and Efficacy Study of ISU302 in Patient With Type I Gaucher Disease

NCT01161914 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Gaucher Disease

Interventions

DRUG: Cerezyme®
DRUG: ISU302

Sponsor

ISU Abxis Co., Ltd.